These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Fibrinolytic enzyme in the lining walls of chronic subdural hematoma. Ito H; Komai T; Yamamoto S J Neurosurg; 1978 Feb; 48(2):197-200. PubMed ID: 146730 [TBL] [Abstract][Full Text] [Related]
23. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891 [TBL] [Abstract][Full Text] [Related]
24. Proteolysis of milk proteins during involution of the bovine mammary gland. Aslam M; Hurley WL J Dairy Sci; 1997 Sep; 80(9):2004-10. PubMed ID: 9313141 [TBL] [Abstract][Full Text] [Related]
25. Effects of native and denatured whey proteins on plasminogen activator activity. Rippel KM; Nielsen SS; Hayes KD J Dairy Sci; 2004 Aug; 87(8):2344-50. PubMed ID: 15328255 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage. Zhang X; Chaudhry A; Chintala SK Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409 [TBL] [Abstract][Full Text] [Related]
27. Expression of the plasminogen system in the physiological mouse ovary and in the pathological polycystic ovary syndrome (PCOS) state. Burchall GF; Pouniotis DS; Teede HJ; Ranasinha S; Walters KA; Piva TJ Reprod Biol Endocrinol; 2019 Mar; 17(1):33. PubMed ID: 30878040 [TBL] [Abstract][Full Text] [Related]
28. Control of plasminogen activator activity in the thecal layer of the largest preovulatory follicle in the hen ovary. Tilly JL; Johnson AL Endocrinology; 1990 Apr; 126(4):2079-87. PubMed ID: 1690637 [TBL] [Abstract][Full Text] [Related]
30. Intrafollicular distribution of plasminogen activators and their hormonal regulation in vitro. Reich R; Miskin R; Tsafriri A Endocrinology; 1986 Oct; 119(4):1588-93. PubMed ID: 3093196 [TBL] [Abstract][Full Text] [Related]
31. Effects of stage of lactation and somatic cell count on plasminogen activator activity in bovine milk. Gilmore JA; White JH; Zavizion B; Politis I J Dairy Res; 1995 Feb; 62(1):141-5. PubMed ID: 7738240 [No Abstract] [Full Text] [Related]
32. Plasmin and plasminogen activators: kinetics, and kinetics of plasminogen activation. Robbins KC; Wohl RC; Summaria L Ann N Y Acad Sci; 1981; 370():588-91. PubMed ID: 6455955 [No Abstract] [Full Text] [Related]
33. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix. Bar-Ner M; Mayer M; Schirrmacher V; Vlodavsky I J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287 [TBL] [Abstract][Full Text] [Related]
34. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine). Petersen LC Eur J Biochem; 1997 Apr; 245(2):316-23. PubMed ID: 9151959 [TBL] [Abstract][Full Text] [Related]
36. Regulation of nonproteolytic active site formation in plasminogen. Gladysheva IP; Sazonova IY; Houng A; Hedstrom L; Reed GL Biochemistry; 2007 Jul; 46(30):8879-87. PubMed ID: 17616171 [TBL] [Abstract][Full Text] [Related]
37. H-D-val-leu-lys-aminoisophthalic acid, dimethyl ester, is sensitive to streptokinase-activator not to plasmin. Ts'ao C; Galluzzo TS Am J Clin Pathol; 1981 Mar; 75(3):372-7. PubMed ID: 6452054 [TBL] [Abstract][Full Text] [Related]
38. Plasminogen activator mediated degradation of subendothelial extracellular matrix by human squamous carcinoma cell lines. Niedbala MJ; Sartorelli AC Cancer Commun; 1990; 2(5):189-99. PubMed ID: 2142433 [TBL] [Abstract][Full Text] [Related]
39. Interaction of a group A Streptococcus within human plasma results in assembly of a surface plasminogen activator that contributes to occupancy of surface plasmin-binding structures. D'Costa SS; Boyle MD Microb Pathog; 1998 Jun; 24(6):341-9. PubMed ID: 9632538 [TBL] [Abstract][Full Text] [Related]
40. Plasminogen activators are involved in angiostatin generation in vivo in benign and malignant ovarian tumor cyst fluids. van Tilborg AA; Sweep FC; Geurts-Moespot AJ; Wetzels AM; de Waal RM; Westphal JR; Massuger LF Int J Oncol; 2014 Apr; 44(4):1394-400. PubMed ID: 24535412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]